GB0804536D0 - Losartan composition - Google Patents

Losartan composition

Info

Publication number
GB0804536D0
GB0804536D0 GBGB0804536.1A GB0804536A GB0804536D0 GB 0804536 D0 GB0804536 D0 GB 0804536D0 GB 0804536 A GB0804536 A GB 0804536A GB 0804536 D0 GB0804536 D0 GB 0804536D0
Authority
GB
United Kingdom
Prior art keywords
losartan
composition
losartan composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0804536.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rosemont Pharmaceuticals Ltd
Original Assignee
Rosemont Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rosemont Pharmaceuticals Ltd filed Critical Rosemont Pharmaceuticals Ltd
Priority to GBGB0804536.1A priority Critical patent/GB0804536D0/en
Publication of GB0804536D0 publication Critical patent/GB0804536D0/en
Priority to PCT/GB2009/000531 priority patent/WO2009112800A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
GBGB0804536.1A 2008-03-12 2008-03-12 Losartan composition Ceased GB0804536D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0804536.1A GB0804536D0 (en) 2008-03-12 2008-03-12 Losartan composition
PCT/GB2009/000531 WO2009112800A1 (en) 2008-03-12 2009-02-25 Losartan composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0804536.1A GB0804536D0 (en) 2008-03-12 2008-03-12 Losartan composition

Publications (1)

Publication Number Publication Date
GB0804536D0 true GB0804536D0 (en) 2008-04-16

Family

ID=39327938

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0804536.1A Ceased GB0804536D0 (en) 2008-03-12 2008-03-12 Losartan composition

Country Status (2)

Country Link
GB (1) GB0804536D0 (en)
WO (1) WO2009112800A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865779B2 (en) 2010-04-15 2014-10-21 Chromocell Corporation Compounds, compositions, and methods for reducing or eliminating bitter taste
AU2011379360B2 (en) 2011-10-20 2016-08-11 Chromocell Corporation Compounds, compositions, and methods for reducing or eliminating bitter taste
WO2020039262A1 (en) * 2018-08-18 2020-02-27 Ftf Pharma Private Limited Pharmaceuticals solution for oral dosage
WO2022076746A1 (en) 2020-10-09 2022-04-14 Scienture, Inc. Losartan liquid formulations and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070026026A1 (en) * 2005-08-01 2007-02-01 David Delmarre Oral liquid losartan compositions

Also Published As

Publication number Publication date
WO2009112800A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
ZA201005268B (en) Composition
GB0815022D0 (en) Composition
GB0819633D0 (en) Composition
GB0822246D0 (en) Composition
GB0801119D0 (en) Composition
GB0818473D0 (en) Composition
GB0810554D0 (en) Herbicde composition
GB0809808D0 (en) Composition
GB0818472D0 (en) Composition
ZA201102726B (en) Composition
GB0801401D0 (en) Composition
GB0811743D0 (en) Composition
EP2357204A4 (en) Composition
GB0810359D0 (en) Composition
GB0817656D0 (en) Composition
GB0804536D0 (en) Losartan composition
GB0812740D0 (en) Composition
GB0806948D0 (en) Composition
ZA201103080B (en) Composition
GB0813589D0 (en) Composition
GB0809983D0 (en) Composition
GB0903681D0 (en) Composition
GB0823344D0 (en) Composition
GB0821754D0 (en) Composition
GB0818231D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)